Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest
Filaggrin is an intermediate filament (IF)-associated protein that aggregates keratin IFs in vitro and is thought to perform a similar function during the terminal differentiation of epidermal keratinocytes. To further explore the role of filaggrin in the cytoskeletal rearrangement that accompanies...
Gespeichert in:
Veröffentlicht in: | Experimental cell research 2001-11, Vol.270 (2), p.199-213 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 213 |
---|---|
container_issue | 2 |
container_start_page | 199 |
container_title | Experimental cell research |
container_volume | 270 |
creator | Presland, Richard B. Kuechle, Melanie K. Lewis, S.Patrick Fleckman, Philip Dale, Beverly A. |
description | Filaggrin is an intermediate filament (IF)-associated protein that aggregates keratin IFs in vitro and is thought to perform a similar function during the terminal differentiation of epidermal keratinocytes. To further explore the role of filaggrin in the cytoskeletal rearrangement that accompanies epidermal differentiation, we generated keratinocyte cell lines that express human filaggrin using a tetracycline-inducible promoter system. Filaggrin expression resulted in reduced keratinocyte proliferation and caused an alteration in cell cycle distribution consistent with a post-G1 phase arrest. Keratin filament distribution was disrupted in filaggrin-expressing lines, while the organization of actin microfilaments and microtubules was more mildly affected. Evidence for direct interaction of filaggrin and keratin IFs was seen by overlay assays of GFP–filaggrin with keratin proteins in vitro and by filamentous filaggrin distribution in cells with low levels of expression. Cells expressing moderate to high levels of filaggrin showed a rounded cell morphology, loss of cell–cell adhesion, and compacted cytoplasm. There was also partial or complete loss of the desmosomal proteins desmoplakin, plakoglobin, and desmogleins from cell–cell borders, while the distribution of the adherens junction protein E-cadherin was not affected. No alterations in keratin cytoskeleton, desmosomal protein distribution, or cell shape were observed in control cell lines expressing β-galactosidase. Filaggrin altered the cell shape and disrupted the actin filament distribution in IF-deficient SW13 cells, demonstrating that filaggrin can affect cell morphology independent of the presence of a cytoplasmic IF network. These studies demonstrate that filaggrin, in addition to its known effects on IF organization, can affect the distribution of other cytoskeletal elements including actin microfilaments, which can occur in the absence of a cytoplasmic IF network. Further, filaggrin can disrupt the distribution of desmosome proteins, suggesting an additional role(s) for this protein in the cytoskeletal and desmosomal reorganization that occurs at the granular to cornified cell transition during terminal differentiation of epidermal keratinocytes. |
doi_str_mv | 10.1006/excr.2001.5348 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1006_excr_2001_5348</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014482701953480</els_id><sourcerecordid>11640884</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-9571affe964247fab5b6c8860f35b3ff960ba6d1375702e437b4044ae80328d63</originalsourceid><addsrcrecordid>eNp1kN1KwzAUx4MoOj9uvZQ8gJ1Jm6bZ5ZibEweC6HVJ05MZzdqRpLLd-QiCb-iTmDrBKyFwQv4fOfwQOqdkSAnhV7BRbpgSQod5xsQeGlAyIknK0nQfDeIzS5hIiyN07P0LIUQIyg_REaWcxTsboI8HWHZWBqjxdLN24L1pG9xqPO9WssEzY-Vy6UyD47kDJ4NpWrUN4PED-M4G3wuTbWj9K1gI0uJr4123DrHmEi9a7_uyCVj79f7ZDzyun8H_qLKpf5SYVxbw2MXvwyk60NJ6OPudJ-hpNn2czJPF_c3tZLxIVFbkIRnlBZVaw4izlBVaVnnFlRCc6CyvMq1HnFSS1zSaC5ICy4qKEcYkCJKloubZCRruepWLSzrQ5dqZlXTbkpKyR1v2aMsebdmjjYGLXWDdVSuo_-y_LKNB7AwQ134z4EqvDDQKauNAhbJuzX_d35H4iq0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Presland, Richard B. ; Kuechle, Melanie K. ; Lewis, S.Patrick ; Fleckman, Philip ; Dale, Beverly A.</creator><creatorcontrib>Presland, Richard B. ; Kuechle, Melanie K. ; Lewis, S.Patrick ; Fleckman, Philip ; Dale, Beverly A.</creatorcontrib><description>Filaggrin is an intermediate filament (IF)-associated protein that aggregates keratin IFs in vitro and is thought to perform a similar function during the terminal differentiation of epidermal keratinocytes. To further explore the role of filaggrin in the cytoskeletal rearrangement that accompanies epidermal differentiation, we generated keratinocyte cell lines that express human filaggrin using a tetracycline-inducible promoter system. Filaggrin expression resulted in reduced keratinocyte proliferation and caused an alteration in cell cycle distribution consistent with a post-G1 phase arrest. Keratin filament distribution was disrupted in filaggrin-expressing lines, while the organization of actin microfilaments and microtubules was more mildly affected. Evidence for direct interaction of filaggrin and keratin IFs was seen by overlay assays of GFP–filaggrin with keratin proteins in vitro and by filamentous filaggrin distribution in cells with low levels of expression. Cells expressing moderate to high levels of filaggrin showed a rounded cell morphology, loss of cell–cell adhesion, and compacted cytoplasm. There was also partial or complete loss of the desmosomal proteins desmoplakin, plakoglobin, and desmogleins from cell–cell borders, while the distribution of the adherens junction protein E-cadherin was not affected. No alterations in keratin cytoskeleton, desmosomal protein distribution, or cell shape were observed in control cell lines expressing β-galactosidase. Filaggrin altered the cell shape and disrupted the actin filament distribution in IF-deficient SW13 cells, demonstrating that filaggrin can affect cell morphology independent of the presence of a cytoplasmic IF network. These studies demonstrate that filaggrin, in addition to its known effects on IF organization, can affect the distribution of other cytoskeletal elements including actin microfilaments, which can occur in the absence of a cytoplasmic IF network. Further, filaggrin can disrupt the distribution of desmosome proteins, suggesting an additional role(s) for this protein in the cytoskeletal and desmosomal reorganization that occurs at the granular to cornified cell transition during terminal differentiation of epidermal keratinocytes.</description><identifier>ISSN: 0014-4827</identifier><identifier>EISSN: 1090-2422</identifier><identifier>DOI: 10.1006/excr.2001.5348</identifier><identifier>PMID: 11640884</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adherens Junctions - metabolism ; Animals ; Anti-Bacterial Agents - pharmacology ; apoptosis ; Apoptosis - physiology ; Cadherins - metabolism ; Cell Adhesion - physiology ; cell cycle ; Cell Division - physiology ; Cell Line ; Cell Size - physiology ; Cytoskeletal Proteins - metabolism ; cytoskeleton ; Cytoskeleton - physiology ; Cytoskeleton - ultrastructure ; Desmogleins ; Desmoplakins ; Desmosomes - metabolism ; Epidermis - cytology ; filaggrin ; gamma Catenin ; Gene Expression - drug effects ; Gene Expression - physiology ; Humans ; In Vitro Techniques ; Intermediate Filament Proteins - analysis ; Intermediate Filament Proteins - genetics ; Intermediate Filament Proteins - metabolism ; Intermediate Filaments - metabolism ; keratinocyte ; Keratinocytes - chemistry ; Keratinocytes - cytology ; Keratinocytes - physiology ; Keratins - metabolism ; Microscopy, Immunoelectron ; Rats ; Tetracycline - pharmacology ; Vimentin - genetics ; Vimentin - metabolism</subject><ispartof>Experimental cell research, 2001-11, Vol.270 (2), p.199-213</ispartof><rights>2001 Academic Press</rights><rights>Copyright 2001 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-9571affe964247fab5b6c8860f35b3ff960ba6d1375702e437b4044ae80328d63</citedby><cites>FETCH-LOGICAL-c375t-9571affe964247fab5b6c8860f35b3ff960ba6d1375702e437b4044ae80328d63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/excr.2001.5348$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11640884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Presland, Richard B.</creatorcontrib><creatorcontrib>Kuechle, Melanie K.</creatorcontrib><creatorcontrib>Lewis, S.Patrick</creatorcontrib><creatorcontrib>Fleckman, Philip</creatorcontrib><creatorcontrib>Dale, Beverly A.</creatorcontrib><title>Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest</title><title>Experimental cell research</title><addtitle>Exp Cell Res</addtitle><description>Filaggrin is an intermediate filament (IF)-associated protein that aggregates keratin IFs in vitro and is thought to perform a similar function during the terminal differentiation of epidermal keratinocytes. To further explore the role of filaggrin in the cytoskeletal rearrangement that accompanies epidermal differentiation, we generated keratinocyte cell lines that express human filaggrin using a tetracycline-inducible promoter system. Filaggrin expression resulted in reduced keratinocyte proliferation and caused an alteration in cell cycle distribution consistent with a post-G1 phase arrest. Keratin filament distribution was disrupted in filaggrin-expressing lines, while the organization of actin microfilaments and microtubules was more mildly affected. Evidence for direct interaction of filaggrin and keratin IFs was seen by overlay assays of GFP–filaggrin with keratin proteins in vitro and by filamentous filaggrin distribution in cells with low levels of expression. Cells expressing moderate to high levels of filaggrin showed a rounded cell morphology, loss of cell–cell adhesion, and compacted cytoplasm. There was also partial or complete loss of the desmosomal proteins desmoplakin, plakoglobin, and desmogleins from cell–cell borders, while the distribution of the adherens junction protein E-cadherin was not affected. No alterations in keratin cytoskeleton, desmosomal protein distribution, or cell shape were observed in control cell lines expressing β-galactosidase. Filaggrin altered the cell shape and disrupted the actin filament distribution in IF-deficient SW13 cells, demonstrating that filaggrin can affect cell morphology independent of the presence of a cytoplasmic IF network. These studies demonstrate that filaggrin, in addition to its known effects on IF organization, can affect the distribution of other cytoskeletal elements including actin microfilaments, which can occur in the absence of a cytoplasmic IF network. Further, filaggrin can disrupt the distribution of desmosome proteins, suggesting an additional role(s) for this protein in the cytoskeletal and desmosomal reorganization that occurs at the granular to cornified cell transition during terminal differentiation of epidermal keratinocytes.</description><subject>Adherens Junctions - metabolism</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>apoptosis</subject><subject>Apoptosis - physiology</subject><subject>Cadherins - metabolism</subject><subject>Cell Adhesion - physiology</subject><subject>cell cycle</subject><subject>Cell Division - physiology</subject><subject>Cell Line</subject><subject>Cell Size - physiology</subject><subject>Cytoskeletal Proteins - metabolism</subject><subject>cytoskeleton</subject><subject>Cytoskeleton - physiology</subject><subject>Cytoskeleton - ultrastructure</subject><subject>Desmogleins</subject><subject>Desmoplakins</subject><subject>Desmosomes - metabolism</subject><subject>Epidermis - cytology</subject><subject>filaggrin</subject><subject>gamma Catenin</subject><subject>Gene Expression - drug effects</subject><subject>Gene Expression - physiology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Intermediate Filament Proteins - analysis</subject><subject>Intermediate Filament Proteins - genetics</subject><subject>Intermediate Filament Proteins - metabolism</subject><subject>Intermediate Filaments - metabolism</subject><subject>keratinocyte</subject><subject>Keratinocytes - chemistry</subject><subject>Keratinocytes - cytology</subject><subject>Keratinocytes - physiology</subject><subject>Keratins - metabolism</subject><subject>Microscopy, Immunoelectron</subject><subject>Rats</subject><subject>Tetracycline - pharmacology</subject><subject>Vimentin - genetics</subject><subject>Vimentin - metabolism</subject><issn>0014-4827</issn><issn>1090-2422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kN1KwzAUx4MoOj9uvZQ8gJ1Jm6bZ5ZibEweC6HVJ05MZzdqRpLLd-QiCb-iTmDrBKyFwQv4fOfwQOqdkSAnhV7BRbpgSQod5xsQeGlAyIknK0nQfDeIzS5hIiyN07P0LIUQIyg_REaWcxTsboI8HWHZWBqjxdLN24L1pG9xqPO9WssEzY-Vy6UyD47kDJ4NpWrUN4PED-M4G3wuTbWj9K1gI0uJr4123DrHmEi9a7_uyCVj79f7ZDzyun8H_qLKpf5SYVxbw2MXvwyk60NJ6OPudJ-hpNn2czJPF_c3tZLxIVFbkIRnlBZVaw4izlBVaVnnFlRCc6CyvMq1HnFSS1zSaC5ICy4qKEcYkCJKloubZCRruepWLSzrQ5dqZlXTbkpKyR1v2aMsebdmjjYGLXWDdVSuo_-y_LKNB7AwQ134z4EqvDDQKauNAhbJuzX_d35H4iq0</recordid><startdate>20011101</startdate><enddate>20011101</enddate><creator>Presland, Richard B.</creator><creator>Kuechle, Melanie K.</creator><creator>Lewis, S.Patrick</creator><creator>Fleckman, Philip</creator><creator>Dale, Beverly A.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20011101</creationdate><title>Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest</title><author>Presland, Richard B. ; Kuechle, Melanie K. ; Lewis, S.Patrick ; Fleckman, Philip ; Dale, Beverly A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-9571affe964247fab5b6c8860f35b3ff960ba6d1375702e437b4044ae80328d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adherens Junctions - metabolism</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>apoptosis</topic><topic>Apoptosis - physiology</topic><topic>Cadherins - metabolism</topic><topic>Cell Adhesion - physiology</topic><topic>cell cycle</topic><topic>Cell Division - physiology</topic><topic>Cell Line</topic><topic>Cell Size - physiology</topic><topic>Cytoskeletal Proteins - metabolism</topic><topic>cytoskeleton</topic><topic>Cytoskeleton - physiology</topic><topic>Cytoskeleton - ultrastructure</topic><topic>Desmogleins</topic><topic>Desmoplakins</topic><topic>Desmosomes - metabolism</topic><topic>Epidermis - cytology</topic><topic>filaggrin</topic><topic>gamma Catenin</topic><topic>Gene Expression - drug effects</topic><topic>Gene Expression - physiology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Intermediate Filament Proteins - analysis</topic><topic>Intermediate Filament Proteins - genetics</topic><topic>Intermediate Filament Proteins - metabolism</topic><topic>Intermediate Filaments - metabolism</topic><topic>keratinocyte</topic><topic>Keratinocytes - chemistry</topic><topic>Keratinocytes - cytology</topic><topic>Keratinocytes - physiology</topic><topic>Keratins - metabolism</topic><topic>Microscopy, Immunoelectron</topic><topic>Rats</topic><topic>Tetracycline - pharmacology</topic><topic>Vimentin - genetics</topic><topic>Vimentin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Presland, Richard B.</creatorcontrib><creatorcontrib>Kuechle, Melanie K.</creatorcontrib><creatorcontrib>Lewis, S.Patrick</creatorcontrib><creatorcontrib>Fleckman, Philip</creatorcontrib><creatorcontrib>Dale, Beverly A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Experimental cell research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Presland, Richard B.</au><au>Kuechle, Melanie K.</au><au>Lewis, S.Patrick</au><au>Fleckman, Philip</au><au>Dale, Beverly A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest</atitle><jtitle>Experimental cell research</jtitle><addtitle>Exp Cell Res</addtitle><date>2001-11-01</date><risdate>2001</risdate><volume>270</volume><issue>2</issue><spage>199</spage><epage>213</epage><pages>199-213</pages><issn>0014-4827</issn><eissn>1090-2422</eissn><abstract>Filaggrin is an intermediate filament (IF)-associated protein that aggregates keratin IFs in vitro and is thought to perform a similar function during the terminal differentiation of epidermal keratinocytes. To further explore the role of filaggrin in the cytoskeletal rearrangement that accompanies epidermal differentiation, we generated keratinocyte cell lines that express human filaggrin using a tetracycline-inducible promoter system. Filaggrin expression resulted in reduced keratinocyte proliferation and caused an alteration in cell cycle distribution consistent with a post-G1 phase arrest. Keratin filament distribution was disrupted in filaggrin-expressing lines, while the organization of actin microfilaments and microtubules was more mildly affected. Evidence for direct interaction of filaggrin and keratin IFs was seen by overlay assays of GFP–filaggrin with keratin proteins in vitro and by filamentous filaggrin distribution in cells with low levels of expression. Cells expressing moderate to high levels of filaggrin showed a rounded cell morphology, loss of cell–cell adhesion, and compacted cytoplasm. There was also partial or complete loss of the desmosomal proteins desmoplakin, plakoglobin, and desmogleins from cell–cell borders, while the distribution of the adherens junction protein E-cadherin was not affected. No alterations in keratin cytoskeleton, desmosomal protein distribution, or cell shape were observed in control cell lines expressing β-galactosidase. Filaggrin altered the cell shape and disrupted the actin filament distribution in IF-deficient SW13 cells, demonstrating that filaggrin can affect cell morphology independent of the presence of a cytoplasmic IF network. These studies demonstrate that filaggrin, in addition to its known effects on IF organization, can affect the distribution of other cytoskeletal elements including actin microfilaments, which can occur in the absence of a cytoplasmic IF network. Further, filaggrin can disrupt the distribution of desmosome proteins, suggesting an additional role(s) for this protein in the cytoskeletal and desmosomal reorganization that occurs at the granular to cornified cell transition during terminal differentiation of epidermal keratinocytes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11640884</pmid><doi>10.1006/excr.2001.5348</doi><tpages>15</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4827 |
ispartof | Experimental cell research, 2001-11, Vol.270 (2), p.199-213 |
issn | 0014-4827 1090-2422 |
language | eng |
recordid | cdi_crossref_primary_10_1006_excr_2001_5348 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adherens Junctions - metabolism Animals Anti-Bacterial Agents - pharmacology apoptosis Apoptosis - physiology Cadherins - metabolism Cell Adhesion - physiology cell cycle Cell Division - physiology Cell Line Cell Size - physiology Cytoskeletal Proteins - metabolism cytoskeleton Cytoskeleton - physiology Cytoskeleton - ultrastructure Desmogleins Desmoplakins Desmosomes - metabolism Epidermis - cytology filaggrin gamma Catenin Gene Expression - drug effects Gene Expression - physiology Humans In Vitro Techniques Intermediate Filament Proteins - analysis Intermediate Filament Proteins - genetics Intermediate Filament Proteins - metabolism Intermediate Filaments - metabolism keratinocyte Keratinocytes - chemistry Keratinocytes - cytology Keratinocytes - physiology Keratins - metabolism Microscopy, Immunoelectron Rats Tetracycline - pharmacology Vimentin - genetics Vimentin - metabolism |
title | Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T11%3A53%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulated%20Expression%20of%20Human%20Filaggrin%20in%20Keratinocytes%20Results%20in%20Cytoskeletal%20Disruption,%20Loss%20of%20Cell%E2%80%93Cell%20Adhesion,%20and%20Cell%20Cycle%20Arrest&rft.jtitle=Experimental%20cell%20research&rft.au=Presland,%20Richard%20B.&rft.date=2001-11-01&rft.volume=270&rft.issue=2&rft.spage=199&rft.epage=213&rft.pages=199-213&rft.issn=0014-4827&rft.eissn=1090-2422&rft_id=info:doi/10.1006/excr.2001.5348&rft_dat=%3Cpubmed_cross%3E11640884%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11640884&rft_els_id=S0014482701953480&rfr_iscdi=true |